Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Drievoudige Antihypertensive Behandeling
Insights
This study explores a triple antihypertensive therapy targeting cardiac output, blood volume, and peripheral resistance. A simplified regimen based on heart rate, body weight, and blood pressure is proposed for hypertensive patients.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Hypertension Management
Background:
- Systemic arterial pressure is a key cardiovascular indicator.
- It is primarily influenced by cardiac output, blood volume, and total peripheral resistance.
- Effective hypertension management requires addressing these determinants.
Purpose of the Study:
- To propose a triple antihypertensive therapy.
- To investigate the hemodynamic changes associated with this therapy.
- To present a simplified therapeutic regimen for hypertension.
Main Methods:
- A triple antihypertensive therapy combining beta-blockers, low-sodium diet with diuretics, and vasodilators was considered.
- Hemodynamic changes during therapy were described.
- A simplified regimen based on heart rate, body weight, and arterial blood pressure was discussed.
Main Results:
- The proposed triple therapy directly targets the main determinants of arterial pressure.
- Hemodynamic alterations during this treatment approach were elucidated.
- A practical therapeutic strategy using routinely measurable parameters was outlined.
Conclusions:
- A comprehensive triple antihypertensive therapy can effectively manage blood pressure.
- A simplified approach using heart rate, body weight, and blood pressure is feasible for clinical practice.
- This strategy offers a practical alternative when detailed hemodynamic measurements are unavailable.
Abstract:
The systemic arterial pressure is determined by 1) the cardiac output, 2) the blood volume, and 3) the total peripheral resistance. A triple antihypertensive therapy is therefore considered which interferes primarily with these three factors using 1) beta adrenergic blocking agents, 2) a low sodium diet and diuretics, and 3) vasodilating antihypertensive drugs. The hae-modynamic changes during this therapy are described. Since cardiac output, resistance and blood volume cannot be determined routinely in all hypertensive patients, a therapeutic regimen is discussed based on the determination of 1) rate, 2) body weight and 3) arterial blood pressure.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Antihypertensive Drugs: Action of Diuretics

